Loading...

Cameron Brand

Title(s)Postdoctoral Scholar, Pharmacology
SchoolHealth Sciences
vCardDownload vCard

    Collapse Research 
    Collapse Research Activities and Funding
    Cardioprotective RhoA Signaling in Mitochondrial Quality Control
    NIH/NHLBI F32HL140851Jan 1, 2018 - Dec 31, 2018
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Baldwin TA, Li Y, Brand CS, Watts VJ, Dessauer CW. Insights Into The Regulatory Properties of Human Adenylyl Cyclase Type 9. Mol Pharmacol. 2019 Jan 29. PMID: 30696718.
      View in: PubMed
    2. Suetomi T, Willeford A, Brand CS, Cho Y, Ross RS, Miyamoto S, Brown JH. Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II d Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling. Circulation. 2018 Nov 27; 138(22):2530-2544. PMID: 30571348.
      View in: PubMed
    3. Brand CS, Tan VP, Brown JH, Miyamoto S. RhoA regulates Drp1 mediated mitochondrial fission through ROCK to protect cardiomyocytes. Cell Signal. 2018 Oct; 50:48-57. PMID: 29953931.
      View in: PubMed
    4. Li Y, Baldwin TA, Wang Y, Subramaniam J, Carbajal AG, Brand CS, Cunha SR, Dessauer CW. Loss of type 9 adenylyl cyclase triggers reduced phosphorylation of Hsp20 and diastolic dysfunction. Sci Rep. 2017 07 17; 7(1):5522. PMID: 28717248.
      View in: PubMed
    5. Yung BS, Brand CS, Xiang SY, Gray CB, Means CK, Rosen H, Chun J, Purcell NH, Brown JH, Miyamoto S. Selective coupling of the S1P3 receptor subtype to S1P-mediated RhoA activation and cardioprotection. J Mol Cell Cardiol. 2017 02; 103:1-10. PMID: 28017639.
      View in: PubMed
    6. Brand CS, Sadana R, Malik S, Smrcka AV, Dessauer CW. Adenylyl Cyclase 5 Regulation by Gß? Involves Isoform-Specific Use of Multiple Interaction Sites. Mol Pharmacol. 2015 Oct; 88(4):758-67. PMID: 26206488; PMCID: PMC4576683 [Available on 10/01/16].
    7. Conley JM, Brand CS, Bogard AS, Pratt EP, Xu R, Hockerman GH, Ostrom RS, Dessauer CW, Watts VJ. Development of a high-throughput screening paradigm for the discovery of small-molecule modulators of adenylyl cyclase: identification of an adenylyl cyclase 2 inhibitor. J Pharmacol Exp Ther. 2013 Nov; 347(2):276-87. PMID: 24008337; PMCID: PMC3807067.
    8. Brand CS, Hocker HJ, Gorfe AA, Cavasotto CN, Dessauer CW. Isoform selectivity of adenylyl cyclase inhibitors: characterization of known and novel compounds. J Pharmacol Exp Ther. 2013 Nov; 347(2):265-75. PMID: 24006339; PMCID: PMC3807061.
    9. Pulliainen AT, Pieles K, Brand CS, Hauert B, Böhm A, Quebatte M, Wepf A, Gstaiger M, Aebersold R, Dessauer CW, Dehio C. Bacterial effector binds host cell adenylyl cyclase to potentiate Gas-dependent cAMP production. Proc Natl Acad Sci U S A. 2012 Jun 12; 109(24):9581-6. PMID: 22635269; PMCID: PMC3386119.